医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Taro to Announce First Quarter Results on August 9, 2018

2018年08月03日 AM02:44
このエントリーをはてなブックマークに追加


 

HAWTHORNE, N.Y.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2018, after the close of market on Thursday, August 9, 2018.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180802005744/en/

CONTACT

Taro Pharmaceutical Industries Ltd.
Mariano A. Balaguer
VP,
CFO
914-345-9001
Mariano.Balaguer@taro.com
or
William
J. Coote

AVP, Business Finance, Treasurer and Investor Relations
914-345-9001
William.Coote@taro.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Seoul Viosys’ Violeds Modules Proven to Disinfect 99% of Airborne Viruses in a Recent Testing Result
  • Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan
  • Kaye推出适用于冷链运输市场的Kaye® Log -80℃ 疫苗温度记录器,以满足COVID-19疫苗储存和运输的要求
  • Kaye® (ケイ)は、COVID-19ワクチンの輸送・保管のニーズに応えるためにKaye® ログ -80ワクチン温度ロガーを、コールドチェーン市場向けに導入(発売)します。
  • DNP的新型非接触式透明屏幕可通过手的动作进行操作